11097-48-6

Basic information

• Product Name: C-PEPTIDE (1-35) (HUMAN)
• Synonyms: PROINSULIN (31-65), HUMAN;PROINSULIN C-PEPTIDE (31-65) (HUMAN);C-PEPTIDE (1-35) (HUMAN);arg-arg-glu-ala-glu-asp-leu-gln-val-gly-gln-val-glu-leu-gly-gly-gly-pro-gly-ala-gly-ser-leu-gln-pro-leu-ala-leu-glu-gly-ser-leu-gln-lys-arg;Insulin C chain;H-Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg-OH;C-Peptide huManC-Peptide;Proinsulin connecting peptide (human)
• CAS NO: 11097-48-6
• Molecular Formula: C153H259N49O52
• Molecular Weight: 3617.02
• Mol File: 11097-48-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: −20°C
• Water Solubility: Soluble in water.
• CAS DataBase Reference: C-PEPTIDE (1-35) (HUMAN)(CAS DataBase Reference)
• NIST Chemistry Reference: C-PEPTIDE (1-35) (HUMAN)(11097-48-6)
• EPA Substance Registry System: C-PEPTIDE (1-35) (HUMAN)(11097-48-6)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 11097-48-6(Hazardous Substances Data)

Usage

General Description

C-peptide (1-35) (human) is a synthetic peptide containing 35 amino acids that is derived from human C-peptide. C-peptide is a byproduct of insulin production and is released in equimolar amounts with insulin from pancreatic beta cells. This peptide has been found to have various biological activities including promoting insulin secretion, improving blood glucose control, and protecting against diabetic complications. Additionally, C-peptide has been studied for its potential therapeutic effects in diabetes management and as a potential biomarker for monitoring pancreatic beta cell function.